WINT

Windtree Therapeutics
WINT

Overview Fund Activity
Delisted

WINT was delisted on the 20th of August, 2025.

Back to rankings

27 hedge funds and large institutions have $1.76M invested in Windtree Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
12
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$267K
2
Envestnet Asset Management
2
Envestnet Asset Management
Illinois
$11K
3
RWM
3
Rockwood Wealth Management
Pennsylvania
$21.2K
4
TRCT
4
Tower Research Capital (TRC)
New York
$5K
5
Millennium Management
5
Millennium Management
New York
$18K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$629K
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$128K
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$0
5
Northern Trust
5
Northern Trust
Illinois
$62K
Name Market Value Shares Shares
Change 		Shares
Change %
GI
26
Gradient Investments
Minnesota
$0 23 – –
TCM
27
Tradewinds Capital Management
Washington
$0 400 – –
PA
28
Parallel Advisors
California
$0 11 – –
BBPWM
29
Blue Bell Private Wealth Management
Pennsylvania
$0 5 – –
BCV
30
Banque Cantonale Vaudoise
Switzerland
$0 1 +1 New
1
2